By Tom Zanki
Law360 (January 23, 2019, 9:20 PM EST) -- Biotechnology firm Gossamer Bio Inc. on Wednesday disclosed pricing details for a $230 million initial public offering, using an unconventional route that allows companies to go public without the usual green...Gossamer Bio Seeks $230M IPO Amid Government Shutdown
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login